CILCANE Trademark

Trademark Overview

On Wednesday, September 23, 2015, a trademark application was filed for CILCANE with the United States Patent and Trademark Office. The USPTO has given the CILCANE trademark a serial number of 79176946. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 13, 2023. This trademark is owned by Big DNA Ltd.. The CILCANE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
cilcane

General Information

Serial Number79176946
Word MarkCILCANE
Filing DateWednesday, September 23, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 13, 2023
Registration Number4986005
Registration DateTuesday, June 28, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBig DNA Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB
Party NameBig DNA Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB
Party NameBig DNA Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Monday, October 16, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 22, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, September 21, 2023INVALIDATION PROCESSED
Wednesday, September 13, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, January 13, 2023CANCELLED SECTION 71
Monday, June 28, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, October 21, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, September 30, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 30, 2016FINAL DISPOSITION PROCESSED
Wednesday, September 28, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 28, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, June 2, 2016NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, April 12, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 4, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 4, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 26, 2016ASSIGNED TO LIE
Friday, February 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 1, 2016REFUSAL PROCESSED BY IB
Thursday, January 14, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 14, 2016REFUSAL PROCESSED BY MPU
Wednesday, January 13, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 12, 2016NON-FINAL ACTION WRITTEN
Tuesday, January 12, 2016ASSIGNED TO EXAMINER
Tuesday, December 1, 2015APPLICATION FILING RECEIPT MAILED
Friday, November 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

cilcane cancer treatment preparations pharmaceutical